Cavanagh Bethany J sold BEAM
January 20, 2026 · Form 4 insider transaction
Cavanagh Bethany J sold 3,034 shares of Beam Therapeutics Inc. at $30.12 per share, a transaction worth $91.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
3,034
Price
$30.12
Total value
$91.4K
InsiderCavanagh Bethany J
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 20, 2026
Filing dateJanuary 21, 2026
Shares owned after41,011
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The shares of Common Stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.